AVEO Pharmaceuticals Inc. signed a 12-year lease with BioMed Realty Trust Inc. for 126,000 sq. ft. of office and laboratory space at 650 East Kendall St. in Cambridge, Mass. The property is located in the heart of a biotechnology super-cluster. It is a six-story, 280,000-sq.-ft. research facility supported by six levels of below-grade parking. The building has received Gold LEED certification from the U.S. Green Building Council.

AVEO is a cancer therapeutics company.

“We are pleased to welcome AVEO to 650 East Kendall and Kendall Square, the ideal location for their mission-critical research and clinical development of cancer therapeutics,” said BioMed’s Chairman and CEO Alan D. Gold in a statement. “650 East Kendall was built to the exacting requirements of world-class life science tenants in order to support transformational research, such as AVEO’s new treatments for the medical oncology community and their patients.”